4.7 Article

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis

Avirup Guha et al.

Summary: The incidence of atrial fibrillation (AF) is higher in breast cancer patients, particularly in those with later stages and higher grades of breast cancer. New onset AF after breast cancer diagnosis increases all-cause and cardiovascular mortality. Involving cardio-oncology in the treatment of breast cancer patients who develop AF after diagnosis is recommended to improve their cardiovascular and overall prognosis.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann et al.

Summary: The discipline of Cardio-Oncology focuses on the cardiovascular care of cancer patients and the management of cardiovascular complications of cancer therapies. This document provides consensus definitions for common cardiovascular toxicities and aims to improve communication and outcomes in clinical practice and research.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

Elmir Omerovic et al.

Summary: The scientific statement on the pathophysiology of Takotsubo syndrome discusses various aspects including catecholamines, the sympathetic nervous system, vascular responses, the role of the nervous systems, gender differences, sex hormones, genetics, and chronic abnormalities of cardiovascular physiology in survivors. The limitations of current clinical and preclinical studies, implications for clinical management, and future research perspectives are also highlighted.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system

Elmir Omerovic et al.

Summary: This scientific statement from the Heart Failure Association (HFA) of the European Society of Cardiology focuses on the pathophysiology of Takotsubo syndrome. It provides an overview of the disease and discusses the role of catecholamines and the sympathetic nervous system, as well as their direct effects on myocardial biology. The statement also explores the integrated effects on ventricular haemodynamics.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Review Oncology

Immune-checkpoint inhibitors: long-term implications of toxicity

Douglas B. Johnson et al.

Summary: Immune-checkpoint inhibitors have improved outcomes for advanced-stage solid tumour patients, but they also carry the risk of chronic toxicities that can affect patients' quality of life. While evidence on chronic toxicities is limited, emerging evidence suggests that they may be more common than previously thought. These toxicities can affect various organ systems and may even lead to fatal outcomes. Research on the effects of immune-checkpoint blockade on other immune processes is also important for cancer survivors.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Oncology

Early parental knowledge of late effect risks in children with cancer

Kendall Carpenter et al.

Summary: The study revealed gaps in parental knowledge of potential late effects of childhood cancer treatment, with some risks (such as ototoxicity) being better understood than others (such as infertility). No specific child- or parent-related factors were associated with increased knowledge of late effect risks, suggesting a need for broad interventions.

PEDIATRIC BLOOD & CANCER (2022)

Review Cardiac & Cardiovascular Systems

The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review

James Murray et al.

Summary: This systematic review aimed to establish the effect of exercise on global longitudinal strain (GLS) and left ventricular ejection fraction (LVEF) in breast cancer patients undergoing chemotherapy, to determine if exercise can prevent the development of cancer therapy-related cardiac dysfunction (CTRCD). The findings showed that exercise maintained or improved peak oxygen uptake (VO(2)peak) during chemotherapy, while declines were observed in non-exercising groups. Further research is needed to address the methodological limitations in current studies and understand the true effect of exercise in preventing CTRCD.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer

Maryam Esmaeilzadeh et al.

Summary: This study aimed to diagnose CTRCD using echocardiographic LVEF and strain and biomarkers. The results suggest that a sequential approach combining echocardiographic 3-D LVEF with 2-D GLS and 2-D GCS may provide a timely and accurate diagnosis of CTRCD.

JAMA CARDIOLOGY (2022)

Article Hematology

Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis

Katrina Piedra et al.

Summary: The incidence of venous thromboembolism varies across different regimens in newly diagnosed multiple myeloma patients, with higher rates seen in those treated with KRD induction. The use of low-dose rivaroxaban thromboprophylaxis can mitigate this risk without an observable increase in bleeding rates.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure

Liam S. Couch et al.

Summary: The circulating biomarkers miR-16 and miR-26a were found to be involved in the pathophysiology of Takotsubo syndrome (TTS), sensitizing the heart to TTS-like changes produced by adrenaline. These miRs are associated with anxiety and depression and may provide a mechanism whereby previous stress primes the heart, increasing the likelihood of TTS in the future.

CARDIOVASCULAR RESEARCH (2022)

Review Cardiac & Cardiovascular Systems

Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association

Craig J. Beavers et al.

Summary: In the population of cardio-oncology, drug interactions play a significant role due to the complexity of drugs and potential risks. It is important for clinicians to recognize potential drug-drug interactions to minimize risks in cardiovascular or cancer therapies. This scientific statement provides an overview of pharmacodynamic and pharmacokinetic drug interactions for clinicians treating cancer patients exposed to common cardiovascular and cancer medications.

CIRCULATION (2022)

Article Oncology

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial

Brian Rini et al.

Summary: In the combination treatment of ICIs and VEGFR inhibitors, patients with high baseline troponin T levels are at a higher risk of major adverse cardiovascular events. Routine monitoring of left ventricular ejection fraction is not recommended for asymptomatic patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function

Lucia Mazzolai et al.

Summary: This consensus document provides clinicians with updated information on the management of deep vein thrombosis, including indications for extended anticoagulation, management of cancer patients, and prevention and management of post-thrombotic syndrome. It also highlights the benefits and safety data of new non-vitamin K antagonists oral anticoagulants, as well as the arrival of new antidotes for severe bleeding management.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes

Suleman Aktaa et al.

Summary: This paper describes the methodology used for the development of quality indicators (QIs) by the European Society of Cardiology (ESC) to evaluate cardiovascular care. The four-step process includes identifying key domains of care, constructing candidate QIs, selecting a final set of QIs, and conducting a feasibility assessment.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)

Article Cardiac & Cardiovascular Systems

Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry

Juan Caro-Codon et al.

Summary: This study aimed to investigate the actual usefulness of cardiovascular risk factor assessment in the prognostic evaluation of cancer patients treated with cardiotoxic treatment. The results showed a significant prevalence of cardiovascular risk factors at baseline and during follow-up. The use of Systemic Coronary Risk Estimation (SCORE) for baseline risk assessment predicted severe cardiotoxicity and all-cause mortality. Therefore, it should be considered in the evaluation of cancer patients.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology

Flavio D'Ascenzi et al.

Summary: This review focuses on investigating the origin, prevention, and reversal strategies of cardiac damage, and explores the beneficial effects of physical exercise on cancer patients. It suggests personalized exercise prescriptions and emphasizes the importance of cardiac evaluation in prescribing exercise for these patients.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials

Kuaifa Fang et al.

Summary: The meta-analysis suggested that ACEI/ARB may have benefits on LVEF following chemotherapy, but do not reduce the risk of cardiotoxicity events and may increase the risk of hypotension in cancer patients. Large-scale RCTs are needed to confirm the clinical relevance of these findings.

HEART FAILURE REVIEWS (2021)

Article Oncology

A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors

Patricia Murphy et al.

Summary: A randomized study conducted at UCSF Benioff Children's Hospital Survivorship Clinic found that providing survivors of childhood cancer with a portable Survivor Healthcare Passport can significantly improve and sustain their knowledge of diagnosis, treatment history, and follow-up needs. The passport serves as a tangible educational tool that enhances patient knowledge and can be easily accessed and shared with other healthcare providers to address late effects and follow-up needs.

SUPPORTIVE CARE IN CANCER (2021)

Article Cardiac & Cardiovascular Systems

Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database

Joachim Alexandre et al.

Summary: The emergence of novel anticancer therapies has led to signals of cardiotoxicity, including atrial fibrillation (AF), but data on the liability of anticancer drugs in inducing AF are scarce. A study using the World Health Organization's individual case safety report database, VigiBase(R), identified 19 anticancer drugs significantly associated with AF, with further confirmation needed through dedicated prospective clinical trials. The findings suggest that anticancer drugs themselves could be independent risk factors for AF development, particularly in hematologic malignancies.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Assessment of coronary artery disease during hospitalization for cancer treatment

Simone M. Mrotzek et al.

Summary: This study evaluated the characteristics and outcomes of cancer patients requiring coronary angiography. Most cancer patients presented with acute coronary syndrome, with the most prevalent cancer entities being lymphoma and lung cancer. One-year mortality was significantly higher in cancer patients compared to non-cancer patients.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Article Hematology

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant

Rehab Alblooshi et al.

Summary: Cardiovascular toxicity is a major concern post-allogeneic hematopoietic stem cell transplant, with CHF being the most common cardiovascular event in the first 100 days. Pretransplant MUGA results and cardiovascular risk factors are important predictors of cardiovascular events and survival in this population.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

Letter Respiratory System

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

Mitja Jevnikar et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Urology & Nephrology

Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials

Mohammad Abufaraj et al.

Summary: GnRH antagonists show better safety profiles in terms of overall mortality and cardiovascular events compared to agonists, but have higher rates of injection site reactions.

EUROPEAN UROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy

Walter B. Schiffer et al.

Summary: This was a single-center, retrospective cohort study evaluating the association between vascular calcification on baseline CT imaging and cardiovascular events following ICI. The study found that worse coronary and aortic calcification on pre-treatment CT imaging was associated with cardiovascular events following ICI.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Biochemistry & Molecular Biology

The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients

Xianghua Huang et al.

Summary: Induction therapy with bortezomib may benefit AL amyloidosis patients with low disease burden eligible for ASCT, showing significantly improved efficacy and survival rates compared to other induction therapies or no induction therapy.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)

Article Cardiac & Cardiovascular Systems

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Jean-Philippe Collet et al.

EUROPEAN HEART JOURNAL (2021)

Review Sport Sciences

High-Intensity Interval Training in Older Adults: a Scoping Review

Catherine F. S. Marriott et al.

Summary: The scoping review found that high-intensity interval training (HIIT) is an effective form of exercise for older adults, improving cardiorespiratory fitness and generally well-tolerated. Most studies focused on healthy populations, with limited research on the effects in older adults with cardiovascular diseases, metabolic dysfunctions, etc. Further studies are needed to evaluate the clinical effects of HIIT in a more diverse range of older adult populations.

SPORTS MEDICINE-OPEN (2021)

Article Oncology

Transcatheter Compared With Surgical Aortic Valve Replacement in Patients With Previous Chest-Directed Radiation Therapy

Farhang Yazdchi et al.

Summary: The study compared outcomes of TAVR with SAVR in patients with CRT-AS, showing excellent in-hospital outcomes and better survival with TAVR. While SAVR still has a role in low-risk patients, TAVR is emerging as the standard of care for intermediate-/high-risk CRT-AS patients.

JACC: CARDIOONCOLOGY (2021)

Review Oncology

Cardiovascular Manifestations From Therapeutic Radiation A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society

Joshua D. Mitchell et al.

Summary: Radiation therapy is a key component of cancer treatment, but can have long-term cardiovascular effects such as atherosclerosis and valvular dysfunction. The International Cardio-Oncology Society provides recommendations on cardiovascular management and follow-up, emphasizing early detection of atherosclerotic vascular disease for preventive therapy.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

Remy Dulery et al.

Summary: This study compared clinical outcomes between patients who received post-transplant cydophosphamide (PT-Cy) and patients who did not, finding a higher incidence of early cardiac events in patients who received PT-Cy.

JACC: CARDIOONCOLOGY (2021)

Review Oncology

Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification

Carmen Bergom et al.

Summary: Radiation therapy is crucial in cancer treatment, but radiation-induced cardiac dysfunction remains a concern. Utilizing advanced technology like cardiac imaging and cardiovascular risk assessment can help reduce cardiac risks and guide post-radiotherapy care. Further personalizing radiotherapy based on enhanced dosimetry and comprehensive cardiac toxicity data can minimize cardiac dysfunction.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

Steven Deitelzweig et al.

Summary: This study found that among patients with nonvalvular atrial fibrillation and concurrent cancer, apixaban was associated with lower risk of stroke/systemic embolism and major bleeding compared to warfarin, while dabigatran and rivaroxaban had similar risks. There were variations in risk among different NOACs, but consistent treatment effects were seen across different types of cancer.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Risk of Atrial Fibrillation According to Cancer Type A Nationwide Population-Based Study

Jun Pil Yun et al.

Summary: Patients with cancer have an increased risk of atrial fibrillation (AF), but the impact on AF development varies by cancer type.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer The WECARE Study

Lauren E. Carlson et al.

Summary: The study found that young women treated with radiation therapy for left-sided breast cancer have over twice the risk of coronary artery disease compared to those treated for right-sided breast cancer. Therefore, the laterality of radiation therapy should be considered in the survivorship care of younger breast cancer patients in order to assess the risk of CAD.

JACC: CARDIOONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Cardiorespiratory fitness and survival following cancer diagnosis

Alexander Fardman et al.

Summary: This study aimed to evaluate the association between midlife cardiorespiratory fitness and survival after a subsequent cancer diagnosis. The results showed that higher midlife cardiorespiratory fitness is associated with better survival among cancer patients.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Review Medicine, General & Internal

Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis

Francesca Caspani et al.

Summary: Cardioprotective drugs show a positive effect in preventing anthracycline-induced cardiac damage, with RAAS blockers, beta-blockers, and aldosterone antagonists demonstrating significant benefits in preventing left ventricular ejection fraction reduction based on echocardiographic parameters.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Oncology

Cardiovascular Toxicity and Mortality Associated With Adoptive Cell Therapy and Tumor-infiltrating Lymphocytes for Advanced Stage Melanoma

Michael G. Fradley et al.

Summary: Adoptive cellular therapy with tumor-infiltrating lymphocytes has shown to be effective in treating unresectable stage III/IV metastatic melanoma, despite common cardiovascular toxicities. Research is needed to better understand the mechanisms and prevention strategies to help clinicians manage these complications and reduce risks, as they do not seem to significantly impact patient survival.

JOURNAL OF IMMUNOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Marco Valerio Mariani et al.

Summary: The meta-analysis showed that the use of DOACs in cancer patients with AF was associated with reduced risk of systemic embolism or any stroke, as well as major bleeding, compared to VKAs. However, the reduction in risk for major bleeding or non-major clinically relevant bleeding was not statistically significant when compared to VKAs. Further studies are needed to validate these findings.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Hematology

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Tatjana S. Potpara et al.

Summary: Atrial fibrillation (AF) is a complex condition that requires comprehensive management involving multiple treatment decisions. While the widely used classification based on episode duration and patterns has contributed to better understanding of AF, there is a recognized need for a more multidimensional classification system as treatment options become more complex. The proposal of a structured characterization approach aims to streamline assessment, communication among physicians, and treatment decision-making for optimal management of AF patients.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Cardiac & Cardiovascular Systems

Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy

Matthew Hooks et al.

Summary: The study identified lower left ventricular ejection fraction, late gadolinium enhancement presence, and increased late gadolinium enhancement extent as independent predictors of left ventricular thrombus in non-ischaemic cardiomyopathy. Patients with left ventricular thrombus in non-ischaemic cardiomyopathy had a significantly higher prevalence of thrombi in other cardiac chambers compared to those in ischaemic cardiomyopathy. The 12-month incidence of embolism associated with left ventricular thrombus was not significantly different between non-ischaemic cardiomyopathy and ischaemic cardiomyopathy, but both were higher compared to those with no left ventricular thrombus in non-ischaemic cardiomyopathy.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)

Article Oncology

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function

Katia Khoury et al.

Summary: HER2-targeted therapies are generally safe for breast cancer patients with compromised heart function, with most patients able to complete treatment without cardiac events. Regular multi-disciplinary care is crucial for improved patient outcomes.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Multidisciplinary consensus on cancer management during pregnancy

A. Cubillo et al.

Summary: Cancer during pregnancy requires interdisciplinary collaboration, considering the week of gestation and tumor characteristics. It is strongly recommended that a multidisciplinary team assesses the situation and guides the patient, while specialized obstetricians monitor and manage the fetus.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

The risk of cardiac events in patients receiving immune checkpoint inhibitors a nationwide Danish study

Maria D'Souza et al.

Summary: This study aimed to estimate the risk of cardiac events in lung cancer and malignant melanoma patients treated with immune checkpoint inhibitors. The results showed that patients treated with ICI had increased rates of cardiac events, with higher risks within 6 months of treatment initiation. After 6 months, the risks persisted in both patient groups.

EUROPEAN HEART JOURNAL (2021)

Letter Cardiac & Cardiovascular Systems

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

John R. Power et al.

CIRCULATION (2021)

Review Oncology

Cardiac Safety of Osimertinib: A Review of Data

Michael S. Ewer et al.

Summary: The study evaluated the risk of cardiac failure in patients receiving osimertinib treatment and did not find a causal relationship between osimertinib and cardiac failure. However, it is recommended to monitor patients with cardiac risk factors before treatment with osimertinib.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Simone de Vries et al.

Summary: Compared with the general population, Hodgkin lymphoma survivors have a substantially reduced life expectancy. Therefore, optimal selection of patients for primary CT is crucial, weighing risks of HL relapse and long-term toxicity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Review Cardiac & Cardiovascular Systems

Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation

Seth J. Rotz et al.

Summary: Hematopoietic stem cell transplantation is a potentially curative treatment for various diseases, but it can also lead to significant cardiovascular complications that require pre-transplant evaluation.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Oncology

Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Elvira C. van Dalen et al.

Summary: This study aimed to harmonize international recommendations for coronary artery disease (CAD) surveillance for survivors of childhood, adolescent and young adult cancers. An extensive systematic literature review was conducted to identify a wide range of CAD surveillance recommendations, highlighting the need to focus on the increased risk of CAD among those treated for cancer.

EUROPEAN JOURNAL OF CANCER (2021)

Article Cardiac & Cardiovascular Systems

Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC

Ana Martin Garcia et al.

Summary: This consensus document aims to provide a coordinated, multidisciplinary and practical approach to the stratification, monitoring and treatment of cardiovascular risk in cancer patients.

REVISTA ESPANOLA DE CARDIOLOGIA (2021)

Article Hematology

Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

Walter Ageno et al.

Summary: The Caravaggio study showed that apixaban is a safe alternative to LMWH for the treatment of CAT patients, without an increased risk of gastrointestinal bleeding.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer

Xiaoqian Li et al.

Summary: This study aimed to validate and compare the prognostic performance of generic and cancer-specific scores in PE patients with active cancer. The results showed that cancer-specific PE prognostic scores (RIETE and POMPE-C) outperformed generic scales (PESI and Hestia) in identifying low-risk PE patients suitable for outpatient treatment.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Cardiac & Cardiovascular Systems

Fast Strain-Encoded Cardiac Magnetic Resonance for Diagnostic Classification and Risk Stratification of Heart Failure Patients

Grigorios Korosoglou et al.

Summary: This study compared the ability of fast-strain encoded magnetic resonance cardiac magnetic resonance to classify and risk stratify patients with different stages of chronic heart failure. The percentage of normal myocardium was found to be a better predictor of heart failure stages and outcomes compared to left ventricular ejection fraction.

JACC-CARDIOVASCULAR IMAGING (2021)

Editorial Material Cardiac & Cardiovascular Systems

Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think

Dimitrios Farmakis

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score-Matched Cohort Study

Husam Abdel-Qadir et al.

Summary: The study found that women exposed to statins had a lower risk of heart failure hospital presentations after chemotherapy for early breast cancer involving anthracyclines, with non-significant trends towards lower risk following trastuzumab. These findings support the development of randomized controlled trials of statins for prevention of cardiotoxicity.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Letter Cardiac & Cardiovascular Systems

Procedural and Short-Term Outcomes of Percutaneous Left Atrial Appendage Closure in Patients With Cancer

Toshiaki Isogai et al.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy

Adam Goldman et al.

Summary: This study identified an association between CAR-T therapy and various CPAEs, including tachyarrhythmias, cardiomyopathy, pericardial and pleural disorders, and venous thromboembolic events. These findings should be considered in the assessment and monitoring of CAR-T therapy recipients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study

Daniele Pastori et al.

Summary: This study investigated the impact of cancer on clinical outcomes in atrial fibrillation (AF) patients, as well as the performance of HAS-BLED and CHA(2)DS(2)-VASc scores. The results showed that cancer increased all-cause mortality, major bleeding, and intracranial hemorrhage risk in AF patients. The risk of ischemic stroke varied among different cancer types, with some showing higher bleeding risk compared to thromboembolic risk.

CANCER (2021)

Article Oncology

ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis

Filipe Cirne et al.

Summary: This study found that crizotinib for NSCLC treatment is associated with a higher risk of bradycardia compared to standard chemotherapy. There is no significant difference in bradycardia risk between crizotinib and newer ALK inhibitors.

LUNG CANCER (2021)

Article Cardiac & Cardiovascular Systems

Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acutemyocardial infarction and bleeding in the USA

Chun Shing Kwok et al.

Summary: This study evaluated the rates of readmissions within 90 days for AMI and bleeding among patients with cancer who undergo PCI. The results showed that patients with cancer, especially those with active cancer, have increased risk for readmissions for AMI or bleeding following PCI. The magnitude of risk depends on both cancer type and the presence of metastasis.

EUROPEAN HEART JOURNAL (2021)

Article Oncology

Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy

Katelyn M. Atkins et al.

Summary: This study found that MHD is insufficient to predict LAD V15Gy with confidence, and there is discordance between MHD and LAD V15Gy. For patients with locally advanced NSCLC, isolated low LAD V15Gy can significantly reduce the risk of MACE.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Cardiac & Cardiovascular Systems

Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy

Paaladinesh Thavendiranathan et al.

Summary: This study showed that GLS-guided cardioprotective therapy is effective in preventing reduction in LVEF and development of CTRCD in high-risk patients undergoing potentially cardiotoxic chemotherapy. Although the change in LVEF was not significantly different between the two arms as a whole, patients in the GLS-guided arm had significantly less reduction in LVEF at the 1-year follow-up.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Review Oncology

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions

Kathryn Banfill et al.

Summary: The impact of radiotherapy on the heart is a growing area of interest, with no consistent cardiac dose-volume constraints identified. While many lung cancer patients undergoing treatment have cardiovascular risk factors, there is limited evidence on the effects of radiotherapy on the heart in these patients.

JOURNAL OF THORACIC ONCOLOGY (2021)

Review Oncology

Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer

Dristhi Ragoonanan et al.

Summary: In this Consensus Statement, updated comprehensive recommendations are provided for managing toxicities from cancer immunotherapies in children, adolescents and young adults. The recommendations emphasize the importance of minimizing toxicities, adopting age-based and discipline-specific management criteria, and early critical care assessment. Advocacy for increased inclusion of young cancer patients in well-designed clinical trials is also highlighted.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

EACVI recommendations on cardiovascular imaging for the detection of embolic sources: endorsed by the Canadian Society of Echocardiography

Ariel Cohen et al.

Summary: Cardioaortic embolism to the brain is a common cause of ischemic strokes, often referred to as 'cardioembolic stroke'. The diagnosis of cardioembolic stroke remains challenging, with up to 30% of cases classified as cryptogenic strokes. Various cardiac imaging modalities, such as TTE, TOE, CT, and MRI, play an important role in identifying potential sources of embolism, with contrast TTE/TOE showing high accuracy in detecting specific conditions.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)

Article Cardiac & Cardiovascular Systems

Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer

Kanae Hasegawa et al.

Summary: Medical castration can prolong QT/QTc intervals in prostate cancer patients, and may cause TdP/VFs even in patients without risk of QT prolongation before therapy. An increase in QTc interval >50 ms from baseline could be a predictor of TdP/VF. Close attention to QTc interval throughout medical castration is crucial in preventing malignant arrhythmias.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Review Oncology

Association of Breast Cancer Irradiation With Cardiac Toxic Effects A Narrative Review

Icro Meattini et al.

Summary: It is crucial to promptly recognize and manage cardiovascular risk factors before, during, and after cancer treatment to decrease the risk of cancer therapy-related cardiac dysfunction. Tumors in the left breast, presence of classic cardiovascular risk factors, and adjunctive anthracycline-based chemotherapy may increase the risk of heart disease. Additional research is needed to confirm the feasibility of pharmacological cardioprevention strategies in routine practice.

JAMA ONCOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis

Mohamed O. Mohamed et al.

Summary: This study analyzed data from STEMI patients in the National Inpatient Sample from 2004 to 2015 and found that despite lower rates of adverse events and all-cause mortality associated with pPCI in patients with current cancer, the utilization of pPCI in these patients was low. Further research is needed to assess the long-term benefits and safety of pPCI in this high-risk group.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)

Article Hematology

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Gary H. Lyman et al.

Summary: These evidence-based guidelines aim to support decision-making on the prevention and treatment of VTE in cancer patients, covering mechanical and pharmacological prophylaxis, as well as recommendations for initial, short-term, and long-term treatment based on patient risk and treatment circumstances. Recommendations vary depending on patient risk level and treatment situation.

BLOOD ADVANCES (2021)

Article Cardiac & Cardiovascular Systems

Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT

Daniel Finke et al.

Summary: The study aimed to detect ICI-associated myocarditis using FAPI PET/CT imaging, comparing enrichment of markers in patients with and without cardiac disease signs. Three patients with suspected ICI-associated myocarditis showed distinct marker enrichment compared to patients without adverse effects or cardiac impairment, further confirmed through cardiac assessments and myocardial biopsies.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Oncology

Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer

Nicolo Matteo Luca Battisti et al.

Summary: Trastuzumab improves survival in patients with HER2+ early breast cancer, but cardiotoxicity remains a concern. The study found that cardiotoxicity was relatively common, but symptomatic heart failure on trastuzumab was rare in the cohort. The HFA-ICOS score can help identify patients at high risk of cardiotoxicity.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Review Oncology

Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports

Alessandro Inno et al.

Summary: The majority of ICI-associated pericardial disease cases were reversible with treatment, although there were reported deaths. For G3-G4 pericarditis and G2 pericarditis with moderate-severe effusion, discontinuation of ICI treatment, high-dose steroids, and additional procedures like pericardiocentesis are recommended.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Pharmacology & Pharmacy

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer

ZiYan Yang et al.

Summary: Breast cancer is the most common form of cancer in women and HER2 overexpression is responsible for a percentage of cases. HER2-targeted therapy has improved survival rates, but concerns about cardiotoxicity remain, with possible mechanisms linked to mitochondrial ROS increase and cell apoptosis. Monitoring NT-proBNP levels may aid in predicting and managing this cardiotoxicity.

FRONTIERS IN PHARMACOLOGY (2021)

Review Oncology

Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)

Teresa Lopez-Fernandez et al.

Summary: Hematopoietic stem cell transplantation is considered a potentially curative option for many hemopathies since 1957, but survivors are at high cardiovascular risk. Advancements in techniques and strategies have reduced treatment-related mortality, leading to a growing number of HSCT survivors anticipated to exceed half a million by 2030.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by the deposition of amyloid fibrils in the heart. With advances in imaging techniques and non-invasive diagnosis, it is now recognized as more common than traditionally believed. The Working Group on Myocardial and Pericardial Disease has proposed definitions, diagnostic algorithms, and treatment strategies to help bridge the gap between the latest research and clinical practice in managing cardiac amyloidosis.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Review Cardiac & Cardiovascular Systems

Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients

Srilakshmi Vallabhaneni et al.

Summary: Cardiovascular magnetic resonance (CMR) plays a crucial role in cardio-oncology by identifying early signs of potential chemotherapy-related cardiac dysfunction and guiding appropriate treatment. Multiparametric analysis with myocardial strain and tissue characterization is essential for addressing important clinical questions in this field.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)

Article Oncology

68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis

Sarah Boughdad et al.

Summary: This study aimed to evaluate the value of Ga-68-DOTATOC PET/CT for the early detection and diagnosis of ICI-related myocarditis. The research found that Ga-68-DOTATOC PET/CT is a highly sensitive method that can effectively detect early myocardial inflammation, especially useful for patients with concomitant myositis.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Biochemistry & Molecular Biology

State-of-Art of Cellular Therapy for Acute Leukemia

Jong-Bok Lee et al.

Summary: Immunotherapy has emerged as the fourth pillar of cancer treatment thanks to recent clinical breakthroughs, with immune cell-based therapies showing promise for potentially curative treatment of leukemia patients. However, the use of different immune cell lineages and subsets against various types of leukemia and patient disease statuses presents challenges in interpreting the clinical applicability and outcomes of these therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cardiac & Cardiovascular Systems

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis

Paaladinesh Thavendiranathan et al.

Summary: Myocarditis as a complication of immune checkpoint inhibitor therapy can be fatal, and the utility of CMR T1 and T2 mapping in these patients is limited. This study found that abnormal T1 and T2 values were common among patients with ICI myocarditis, and some patients met the criteria for nonischemic myocardial injury and myocardial edema.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Oncology

The Role of Healthy Lifestyle in Cancer Incidence and Temporal Transitions to Cardiometabolic Disease

Zhi Cao et al.

Summary: This study found that a healthy lifestyle can slow down the transition from cancer development to subsequent CVD and T2D, and also reduce the risk of CVD and T2D in cancer survivors.

JACC: CARDIOONCOLOGY (2021)

Editorial Material Oncology

Healthy Lifestyle Benefits Both Cancer and Cardiovascular Disease

Erin D. Michos et al.

JACC: CARDIOONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer Comparison With Echocardiography

Christian P. Houbois et al.

Summary: In early stage breast cancer patients, changes observed in CMR and 2DE strain, left ventricular ejection fraction, and LVESVi can be used as prognostic indicators for subsequent CTRCD. Two-dimensional echocardiography strain measurement (2DE-GLS) provided the highest increase in discriminatory value over baseline clinical risk factors for subsequent CTRCD.

JACC-CARDIOVASCULAR IMAGING (2021)

Article Oncology

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study

Michal Wilk et al.

Summary: The presence of well-controlled hypertension, stable coronary artery disease, and the use of angiotensin system inhibitors (ASi) were associated with longer time to treatment failure (TTF) in post-chemotherapy mCRPC patients receiving ABI therapy. These factors may potentially serve as non-oncological predictive markers for prolonged ABI therapy.

FRONTIERS IN ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association

Tochi M. Okwuosa et al.

Summary: Cardiovascular disease and cancer are the leading causes of death in the United States. Hormone-dependent cancers, such as breast and prostate cancer, are common and their treatments with hormonal therapies can improve survival but also increase cardiovascular risks. This consensus statement highlights the importance of preventing and detecting adverse cardiovascular outcomes, while also addressing uncertainties and challenges in this area.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)

Review Biophysics

Cardiac complications associated with hematopoietic stem-cell transplantation

Akihiro Ohmoto et al.

Summary: Advances in chemotherapy and supportive therapy have improved clinical outcomes for hematological malignancy patients undergoing HSCT. However, the association between HSCT and cardiotoxicity remains controversial. Monitoring cardiac function, genetic analysis, and collaboration between oncologists and cardiologists are crucial for preventing cardiac complications in these patients.

BONE MARROW TRANSPLANTATION (2021)

Review Oncology

Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis

Mary Obasi et al.

Summary: The study investigated the role of statins in mitigating cardiotoxicity in cancer patients receiving anthracyclines and/or trastuzumab, finding that statin use was significantly associated with decreased risk of cardiotoxicity and improved left ventricular ejection fraction maintenance. Larger, well-conducted randomized controlled trials are needed to further explore the potential benefits of statins in reducing cardiotoxicity.

CANCER CAUSES & CONTROL (2021)

Review Cardiac & Cardiovascular Systems

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association

Michael G. Fradley et al.

Summary: With advancements in cancer treatments, heart arrhythmias are becoming a common complication among cancer patients, presenting unique challenges for management. Despite increasing recognition, there is a lack of dedicated prospective studies evaluating the true incidence of arrhythmias in this population.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up

Sorin Giusca et al.

Summary: The study found that the percentage of normal myocardium derived from fast-strain-encoded cardiovascular magnetic resonance can more accurately detect and predict cardiac dysfunction in cancer patients undergoing cardiotoxic chemotherapy, demonstrating good performance in predicting who will develop CTX.

CIRCULATION-CARDIOVASCULAR IMAGING (2021)

Article Cardiac & Cardiovascular Systems

Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study

Husam Abdel-Qadir et al.

Summary: This study focused on the prognosis of heart failure (HF) in women who developed HF after receiving anthracyclines or trastuzumab for early stage breast cancer. The results showed that patients with cardiotoxic exposure had fewer comorbidities compared to age-matched controls, and those who developed HF after trastuzumab treatment had a better prognosis than HF controls.

CIRCULATION-HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Anticancer drug-induced life-threatening ventricular arrhythmias: a World health Organization pharmacovigilance study

Joe-Elie Salem et al.

Summary: The study compared the risk of drug-induced long QT and ventricular arrhythmias for 663 anticancer drugs with other drugs, proposing a three-level sudden death risk stratification based on the findings. This list of potentially dangerous anticancer drugs may be helpful for physicians and regulatory authorities in reassessing cardiac monitoring requirements.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Satin associated lower cancer risk and related mortaity in patients with heart failure

Qing-Wen Ren et al.

Summary: This study suggests that statin use is associated with a significantly lower risk of incident cancer and cancer-related mortality in patients with heart failure, and this association appears to be duration dependent.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis

Charles Dolladille et al.

Summary: In randomized clinical trials, the use of ICIs is associated with six CV irAEs, including myocarditis and pericarditis, with incidences ranging from 3.2 to 19.3 per 1000 patients and a median follow-up ranging from 3.2 to 32.8 months.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis

Nestor Rubio-Infante et al.

Summary: This study estimated the incidence of cardiac irAEs in patients treated with ICIs, finding myocarditis to be the most frequent one. Despite the low incidence, the high mortality rate associated with cardiac irAEs is an important consideration. Dual ICI therapies seem to provoke higher rates of cardiac irAEs than monotherapies or ICIs plus chemotherapy.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy

Nicolas L. Palaskas et al.

Summary: A grading system was developed for ICI myocarditis based on degree of inflammatory infiltrate, with some patients able to continue ICI without immunosuppressive therapy and have good cardiovascular outcomes. Further studies are needed to identify low-risk patients who can safely receive ICI therapy.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Oncology

Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study

Husam Abdel-Qadir et al.

Summary: The study found that ibrutinib treatment in CLL patients is associated with higher risks of atrial fibrillation, bleeding, and heart failure, but not myocardial infarction or stroke.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

John C. Byrd et al.

Summary: In this study, acalabrutinib was found to be noninferior to ibrutinib in terms of progression-free survival in patients with CLL, with a lower incidence of cardiovascular adverse events. This suggests that acalabrutinib may be a more tolerable option for continuous therapy in this patient population.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents JACC State-of-the-Art Review

Vijay U. Rao et al.

Summary: Precision medicine has revolutionized cancer treatment by introducing targeted therapies, improving overall survival rates. Oral molecular targeted antineoplastic agents offer enhanced patient convenience and reduced risk of adverse effects, however, cardiovascular toxicities are becoming more prevalent and require focused monitoring and management to optimize patient outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

E. Kastritis et al.

Summary: In patients with newly diagnosed AL amyloidosis, adding daratumumab to bortezomib, cyclophosphamide, and dexamethasone resulted in higher rates of hematologic complete response and improved survival outcomes. However, adverse events, including lymphopenia, pneumonia, cardiac failure, and diarrhea, were more common in the daratumumab group. Most deaths were due to amyloidosis-related cardiomyopathy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Hematology

Safety of FLT3 inhibitors in patients with acute myeloid leukemia

Claudio Cerchione et al.

Summary: FLT3 inhibitors have shown effective therapeutic strategies for treating FLT3(mut) AML patients, but unique toxicities and drug-drug interactions need to be resolved. Research on their combinations with other drugs and their application in different clinical settings is ongoing.

EXPERT REVIEW OF HEMATOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology

Eve Belzile-Dugas et al.

Summary: Radiation therapy can lead to a wide array of cardiovascular complications, often overlooked by clinicians. This population has a higher risk of cardiovascular diseases and tend to have worse outcomes compared to traditional counterparts. Referral for percutaneous management is recommended for these patients when appropriate.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Oncology

Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban

Yu-Sheng Lin et al.

Summary: Dabigatran may be associated with a lower risk of cancer-related death and all-cause mortality compared with rivaroxaban, as well as lower risks of major bleeding and GI bleeding.

CANCER MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis A Narrative Review

Lorenz H. Lehmann et al.

Summary: ICIs have become an important treatment option for various cancer types, but their use is associated with the risk of myocarditis. The diagnosis of ICI-associated myocarditis can be challenging and relies on a combination of clinical suspicion, cardiac biomarkers, imaging, and endomyocardial biopsy. Combining different types of ICIs may increase the risk of developing myocarditis.

JAMA CARDIOLOGY (2021)

Article Oncology

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R. Brahmer et al.

Summary: ICIs are standard treatments for cancer, but come with risks of immune-related adverse events. The SITC convened an expert panel to develop guidelines for managing irAEs, aiming to improve patient outcomes through evidence-based recommendations.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Pericardial disease in patients treated with immune checkpoint inhibitors

Jingyi Gong et al.

Summary: ICI use was associated with an increased risk of development of pericardial disease among patients with cancer and a pericardial event on an ICI was associated with a trend towards increase in mortality.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Medicine, General & Internal

Statin Use Can Attenuate the Decline in Left Ventricular Ejection Fraction and the Incidence of Cardiomyopathy in Cardiotoxic Chemotherapy Recipients: A Systematic Review and Meta-Analysis

Jean Kim et al.

Summary: This study found a significant reduction in the incidence of chemotherapy-induced cardiomyopathy and the degree of left ventricular ejection fraction decline in patients who received concurrent statin therapy compared to those who received chemotherapy alone.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases

Sofie A. Gevaert et al.

Summary: With advances in treatment and aging of the population, more cancer patients are presenting with acute cardiovascular diseases, which requires acute cardiac care specialists to be aware of and manage these complications. An individualized and multidisciplinary approach may be necessary, with close collaboration between acute cardiologists and other oncology specialists.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)

Review Oncology

Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy

D. Delombaerde et al.

Summary: Cardiovascular adverse events induced by immune checkpoint inhibitors have gained significant interest, with increasing discussions regarding their impact. Currently, there are no specific guidelines for the interpretation of asymptomatic rise in troponins.

ESMO OPEN (2021)

Review Health Care Sciences & Services

Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review

Yukai Chen et al.

Summary: Two cases of myocarditis developed after PD-1 inhibitors therapy were reported, with different treatment approaches and outcomes. Early detection and timely intervention are crucial for improving prognosis.

ANNALS OF PALLIATIVE MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management

Giuseppe Boriani et al.

Summary: The survey highlights the challenges in managing anticoagulation in patients with AF and active cancer, with substantial heterogeneity in therapeutic choices. Despite the emerging role of DOACs, the substantial use of LMWH continues, despite the lack of long-term data on thromboprophylaxis in AF.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Article Oncology

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity JACC: CardioOncology Primer

Lili Zhang et al.

Summary: ICIs are newer therapies being increasingly applied to cancer patients, but the complexity in diagnosing ICI-related cardiotoxicity is increasing. Research and continued collaborations are urgently needed to provide evidence-based cardiovascular care for this rapidly expanding and vulnerable cohort of patients.

JACC: CARDIOONCOLOGY (2021)

Article Oncology

Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer

Jan M. Leerink et al.

Summary: In childhood cancer survivors (CCS), the addition of initial surveillance EF to anthracyclines and chest-directed radiotherapy dose improves the 10-year prediction for LVD40. This can help identify both low-risk survivors who may have reduced surveillance frequency and survivors at increased risk of LVD40.

JACC: CARDIOONCOLOGY (2021)

Article Hematology

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A US Claims Data Analysis

Alexander Cohen et al.

Summary: This study found that VTE and active cancer patients initiating apixaban had a lower risk of recurrent VTE and MB compared to LMWH patients. Apixaban patients also had a lower risk of recurrent VTE compared to warfarin patients.

THROMBOSIS AND HAEMOSTASIS (2021)

Review Biophysics

Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation

Guilherme H. Oliveira et al.

Summary: This review provides a framework for cardiovascular evaluation and management of patients undergoing hematopoietic cell transplantation (HCT), emphasizing the importance of cardiovascular risk and risk mitigation as well as the mechanisms of HCT-induced cardiovascular injury. It also presents an algorithm for cardiovascular testing and management of cardiovascular conditions associated with HCT recipients.

BONE MARROW TRANSPLANTATION (2021)

Article Oncology

Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort

Stephanie B. Dixon et al.

Summary: Cardiac biomarkers, particularly NT-proBNP, can help identify survivors of childhood cancer at increased risk for future cardiomyopathy, especially in those without a history of cardiomyopathy or current systolic dysfunction. Longitudinal studies are needed to confirm this finding.

CANCER (2021)

Article Cardiac & Cardiovascular Systems

The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study

Maria D'Souza et al.

Summary: This study aimed to estimate the risk of cardiac events in lung cancer or malignant melanoma patients treated with immune checkpoint inhibitors (ICIs). The results showed that patients treated with ICIs had higher rates of cardiac events, with significantly increased absolute risks within 1 year of treatment.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Statin associated lower cancer risk and related mortality in patients with heart failure

Qing-Wen Ren et al.

Summary: The study suggests that statin use is associated with a significantly lower risk of incident cancer and cancer-related mortality in patients with heart failure, and this association appears to be dependent on the duration of statin use.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis

Andrea Baggiano et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Cardiac & Cardiovascular Systems

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Francesco Cosentino et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy

Jenica N. Upshaw et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Oncology

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials

Evandro de Azambuja et al.

BREAST CANCER RESEARCH AND TREATMENT (2020)

Article Cardiac & Cardiovascular Systems

Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50years

Judy N. Jacobse et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis

Lars Michel et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Hematology

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Cardiac & Cardiovascular Systems

Association between statin use and all-cause mortality in cancer survivors, based on the Korean health insurance service between 2002 and 2015

Joungyoun Kim et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

Article Cardiac & Cardiovascular Systems

Contemporary Trends and Outcomes of Percutaneous and Surgical Mitral Valve Replacement or Repair in Patients With Cancer

Avirup Guha et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Cardiology care delivered to cancer patients

Riccardo Asteggiano et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

Jose Lopez-Sendon et al.

EUROPEAN HEART JOURNAL (2020)

Review Cardiac & Cardiovascular Systems

Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes

Massimo Imazio et al.

HEART (2020)

Article Cardiac & Cardiovascular Systems

Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity

James Lambert et al.

HEART (2020)

Review Cardiac & Cardiovascular Systems

Management of Acute and Recurrent Pericarditis JACC State-of-the-Art Review

Juan Guido Chiabrando et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis

Magid Awadalla et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

Dennis J. Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Oncology

Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors

Charles Dolladille et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Cardiac & Cardiovascular Systems

Radiotherapy in Patients With a Cardiac Implantable Electronic Device

Ardalan Sharifzadehgan et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Article Hematology

Multiple myeloma: 2020 update on diagnosis, risk-stratification and management

S. Vincent Rajkumar

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Biniyam G. Demissei et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Multidisciplinary Sciences

Fatal heart disease among cancer patients

Kelsey C. Stoltzfus et al.

NATURE COMMUNICATIONS (2020)

Letter Cardiac & Cardiovascular Systems

Cardiac Events Associated With Chimeric Antigen Receptor T-Cells (CAR-T) A VigiBase Perspective

Joe-Elie Salem et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Environmental Sciences

Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds

Javad Sharifi-Rad et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Cardiac & Cardiovascular Systems

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

Joerg Herrmann

NATURE REVIEWS CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Vascular toxic effects of cancer therapies

Joerg Herrmann

NATURE REVIEWS CARDIOLOGY (2020)

Article Medicine, General & Internal

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

Neal D. Shore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial

Jennifer M. T. A. Meessen et al.

ESC HEART FAILURE (2020)

Article Oncology

Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study

Amber Afzal et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)

Article Cardiac & Cardiovascular Systems

Focused echocardiography in cardio-oncology

Kalliopi Keramida et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2020)

Review Cardiac & Cardiovascular Systems

Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis

Shannon K. Parr et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Oncology

Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

Efstathios Kastritis et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations

Michelle C. Turner et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Cardiac & Cardiovascular Systems

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque

Zsofia D. Drobni et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association

James E. Tisdale et al.

CIRCULATION (2020)

Review Cardiac & Cardiovascular Systems

The cancer patient and cardiology

Jose Luis Zamorano et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Diagnostic Accuracy of Cardiac Computed Tomography and 18-F Fluorodeoxyglucose Positron Emission Tomography in Cardiac Masses

Emanuela Concetta D'Angelo et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Review Cardiac & Cardiovascular Systems

The Role of Biomarkers in Cardio-Oncology

Kajaluxy Ananthan et al.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Multimodality imaging in cardiac amyloidosis: a primer for cardiologists

Ruxandra Jurcut et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2020)

Article Cardiac & Cardiovascular Systems

Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure

Navin Suthahar et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion

So Ree Kim et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Hematology

Management of AL amyloidosis in 2020

Giovanni Palladini et al.

BLOOD (2020)

Editorial Material Cardiac & Cardiovascular Systems

By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis?

Lavanya Kondapalli et al.

CIRCULATION (2020)

Article Medicine, General & Internal

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Oncology

Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis

Jennifer Cautela et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Oncology

Strain Imaging in Cardio-Oncology

Jennifer E. Liu et al.

JACC: CARDIOONCOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Mediastinal Radiation

Ayman Elbadawi et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2020)

Review Cardiac & Cardiovascular Systems

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy An Expert Consensus Document

Enrico Ammirati et al.

CIRCULATION-HEART FAILURE (2020)

Review Cardiac & Cardiovascular Systems

Outcomes of percutaneous coronary interventions in cancer patients

Aditya S. Bharadwaj et al.

EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2020)

Review Cardiac & Cardiovascular Systems

Ventricular Arrhythmias in Cardiac Amyloidosis: A Review of Current Literature

Shaun Khanna et al.

CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2020)

Article Oncology

Cardiovascular Effects of CAR T Cell Therapy A Retrospective Study

Benedicte Lefebvre et al.

JACC: CARDIOONCOLOGY (2020)

Review Oncology

Cardiac Tumors JACC CardioOncology State-of-the-Art Review

Sara Tyebally et al.

JACC: CARDIOONCOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Incidence of Atrioventricular Block After Valve Replacement in Carcinoid Heart Disease

Igor Sunjic et al.

CARDIOLOGY RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer

John D. Groarke et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2020)

Article Cardiac & Cardiovascular Systems

Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T

Eva Furenas et al.

OPEN HEART (2020)

Review Cardiac & Cardiovascular Systems

Management of Arrhythmias in Cardiac Amyloidosis

Shaun Giancaterino et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications

Peter Ferdinandy et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council

Patrizio Lancellotti et al.

EUROPEAN HEART JOURNAL (2019)

Review Cardiac & Cardiovascular Systems

Cardiovascular toxicities associated with immune checkpoint inhibitors

Jiun-Ruey Hu et al.

CARDIOVASCULAR RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Cardiac arrhythmia considerations of hormone cancer therapies

Mary Barber et al.

CARDIOVASCULAR RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events

William J. Phillips et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

Review Health Care Sciences & Services

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

Lorraine Warrington et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis

Edward A. El-Am et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Anticoagulation Strategies in Patients With Cancer JACC Review Topic of the Week

Ramya C. Mosarla et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Oncology

Risk factors for the development of atrial fibrillation on ibrutinib treatment

Robert Lentz et al.

LEUKEMIA & LYMPHOMA (2019)

Article Medicine, General & Internal

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

A. A. Khorana et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Radiotherapy toxicity

Dirk De Ruysscher et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Review Oncology

Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases

Suheil Albert Atallah-Yunes et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)

Letter Cardiac & Cardiovascular Systems

High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis

Ana Martinez-Naharro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Abordaje de la fibrilación auricular en pacientes con cáncer activo. Documento de consenso de expertos y recomendaciones

Teresa López-Fernández et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2019)

Article Cardiac & Cardiovascular Systems

Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy

Pablo Garcia-Pavia et al.

CIRCULATION (2019)

Article Cardiac & Cardiovascular Systems

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

Christian Mueller et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Cardiac & Cardiovascular Systems

Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study

Vinita Dhir et al.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2019)

Article Cardiac & Cardiovascular Systems

Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer

Maya Guglin et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Medicine, General & Internal

Health Care Spending, Utilization, and Quality 8 Years into Global Payment

Zirui Song et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

S. -A. Im et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure

Usman A. Tahir et al.

SCIENTIFIC REPORTS (2019)

Review Cardiac & Cardiovascular Systems

Radiation-Associated Pericardial Disease

Natalie Szpakowski et al.

CURRENT CARDIOLOGY REPORTS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG-203†

Moyed Miften et al.

MEDICAL PHYSICS (2019)

Letter Oncology

Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis

Yoshito Zamami et al.

JAMA ONCOLOGY (2019)

Article Cardiac & Cardiovascular Systems

A population-based study of cardiovascular diseasemortality risk in US cancer patients

Kathleen M. Sturgeon et al.

EUROPEAN HEART JOURNAL (2019)

Editorial Material Cardiac & Cardiovascular Systems

From trends to transformation: where cardio-oncology is to make a difference

Joerg Herrmann

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Cardiovascular Toxicities Associated With Ibrutinib

Joe-Elie Salem et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Editorial Material Cardiac & Cardiovascular Systems

Cardiovascular Toxicities of Immune Checkpoint Inhibitors JACC Review Topic of the Week

Somedeb Ball et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Hypertension in the Cardio-Oncology Clinic

Lauren J. Hassen et al.

HEART FAILURE CLINICS (2019)

Article Cardiac & Cardiovascular Systems

A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis

Christopher D. Barrett et al.

JACC-HEART FAILURE (2019)

Article

Role of physical therapy pre and post hematopoietic stem cell transplantation – White paper report

Jaleel Mohammed et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Review Hematology

How I treat cancer-associated venous thromboembolism

Noemie Kraaijpoel et al.

BLOOD (2019)

Letter Hematology

Grading cardiac response in AL amyloidosis: implications for relapse and survival

Erik Eckhert et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy

Oscar Calvillo-Arguelles et al.

CANADIAN JOURNAL OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Test-retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function

Tomasz Baron et al.

CLINICAL RESEARCH IN CARDIOLOGY (2019)

Editorial Material Cardiac & Cardiovascular Systems

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States

Jessica E. Potts et al.

EUROPEAN HEART JOURNAL (2019)

Article Medicine, General & Internal

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Vincenzo Livio Malavasi et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)

Review Endocrinology & Metabolism

Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer

Danielle Novetsky Friedman et al.

HORMONE RESEARCH IN PAEDIATRICS (2019)

Article Oncology

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors

Judy N. Jacobse et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Cardiac & Cardiovascular Systems

Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis

Uri Landes et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2019)

Article Cardiac & Cardiovascular Systems

Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial

Maryam Nabati et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Article Cardiac & Cardiovascular Systems

Improving outcome of valve replacement for carcinoid heart disease

Anita Nguyen et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Medicine, General & Internal

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Marc Carrier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

Raza M. Alvi et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors

Nicolas Palaskas et al.

AMERICAN JOURNAL OF CARDIOLOGY (2019)

Review Oncology

Takotsubo cardiomyopathy in cancer patients

Aakash Desai et al.

CARDIO-ONCOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Carcinoid heart disease involving the left heart: a case report and biomarker analysis

Michael Lichtenauer et al.

ESC HEART FAILURE (2019)

Review Cardiac & Cardiovascular Systems

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

Kathleen W. Zhang et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)

Article Oncology

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer

Ariane V. S. Macedo et al.

JACC: CARDIOONCOLOGY (2019)

Article Oncology

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity A Phase I Trial

Darryl P. Leong et al.

JACC: CARDIOONCOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF

Sean T. Chen et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)

Article Respiratory System

Tumoral pulmonary hypertension

Laura C. Price et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Review Medicine, General & Internal

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors A Systematic Review and Meta-analysis

Raluca I. Mincu et al.

JAMA NETWORK OPEN (2019)

Article Cardiac & Cardiovascular Systems

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Marco Valgimigli et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

Alessandra Fornaro et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Letter Oncology

Cardio-oncology in multiple myeloma: is it time for a specific focus?

Salvatrice Mancuso et al.

LEUKEMIA & LYMPHOMA (2018)

Review Cardiac & Cardiovascular Systems

Exercise Therapy and Cardiovascular Toxicity in Cancer

Jessica M. Scott et al.

CIRCULATION (2018)

Letter Cardiac & Cardiovascular Systems

Hypogonadism as a Reversible Cause of Torsades de Pointes in Men

Joe-Elie Salem et al.

CIRCULATION (2018)

Review Medical Laboratory Technology

Novel heart failure biomarkers: why do we fail to exploit their potential?

Arnold Piek et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)

Article Cardiac & Cardiovascular Systems

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management

Jelena-Rima Ghadri et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial

Ann Banke et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Cardiac & Cardiovascular Systems

Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge

Pietro Ameri et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Oncology

Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects

Mariana Brandao et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

Review Cardiac & Cardiovascular Systems

How to prevent and manage radiation-induced coronary artery disease

Jason R. Cuomo et al.

HEART (2018)

Review Cardiac & Cardiovascular Systems

Mechanism and management of cancer-associated thrombosis

Mikio Mukai et al.

JOURNAL OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Elevated Cardiac Troponin T in Patients With Skeletal Myopathies

Johannes Schmid et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

Monica Samuel Avila et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Neoplasia and the Heart Pathological Review of Effects With Clinical and Radiological Correlation

Joseph J. Maleszewski et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed S. Mahmood et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update

Thomas R. Porter et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2018)

Article Medicine, General & Internal

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Medicine, General & Internal

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Pharmacology & Pharmacy

Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms

Joachim Alexandre et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Pharmacology & Pharmacy

Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors

Enrico Bronte et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Letter Cardiac & Cardiovascular Systems

Effect of Traditional Heart Failure Risk Factors on Myocardial Dysfunction in Adult Survivors of Childhood Cancer

Mark T. Nolan et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Article Cardiac & Cardiovascular Systems

Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy

Paaladinesh Thavendiranathan et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Review Oncology

Exercise Training and Cardiovascular Health in Cancer Patients

Ray W. Squires et al.

CURRENT ONCOLOGY REPORTS (2018)

Article Cardiac & Cardiovascular Systems

CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer

Maria D'Souza et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)

Article Critical Care Medicine

Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report

Gregory Y. H. Lip et al.

CHEST (2018)

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Vera Regitz-Zagrosek et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience

Nilesh Pareek et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Oncology

Immune checkpoint inhibitors and cardiovascular toxicity

Alexander R. Lyon et al.

LANCET ONCOLOGY (2018)

Article Medicine, General & Internal

Quality of Care in the United Kingdom after Removal of Financial Incentives

Mark Minchin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Cardiac & Cardiovascular Systems

Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient

Juan Carlos Plana et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Article Medicine, Research & Experimental

Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production

Weijie Du et al.

THERANOSTICS (2018)

Article

Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy

Noelle Frey et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Article Cardiac & Cardiovascular Systems

Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery

Jawad H. Butt et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation Expert Recommendations

Vanessa M. Ferreira et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Cardiorespiratory Fitness and Mortality in Healthy Men and Women

Mary T. Imboden et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

2018 ESC/EACTS Guidelines on myocardial revascularization

Franz-Josef Neumann et al.

KARDIOLOGIA POLSKA (2018)

Review Oncology

5-fluorouracil and cardiotoxicity: a review

Jaskanwal D. Sara et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)

Review Oncology

Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Shagufta Shaheen et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BIeeMACS substudy

Mario Iannaccone et al.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)

Article Oncology

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)

Tait D. Shanafelt et al.

LEUKEMIA & LYMPHOMA (2017)

Article Cardiac & Cardiovascular Systems

Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis

Francesco Salinaro et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)

Review Pharmacology & Pharmacy

Breast cancer treatment-induced cardiotoxicity

Samuel Martel et al.

EXPERT OPINION ON DRUG SAFETY (2017)

Review Cardiac & Cardiovascular Systems

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

Martha Grogan et al.

HEART (2017)

Article Cardiac & Cardiovascular Systems

Prevalence of cancer in Takotsubo cardiomyopathy: Short and long-term outcome

K. Sattler et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Oncology

Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

Matthew S. Ning et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Cardiac & Cardiovascular Systems

Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity

Maryam Nabati et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)

Article Oncology

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Review Cardiac & Cardiovascular Systems

Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 2

Hui-Ming Chang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Cardiac & Cardiovascular Systems

Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors An Expert Statement

Joseph Davar et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Letter Cardiac & Cardiovascular Systems

Cardiac Outcomes With Pregnancy After Cardiotoxic Therapy for Childhood Cancer

Kara A. Thompson et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Risk of Arterial Thromboembolism in Patients With Cancer

Babak B. Navi et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones

Teresa López-Fernández et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2017)

Article Cardiac & Cardiovascular Systems

Nuevas técnicas de imagen cardiaca en la detección precoz de cardiotoxicidad secundaria a tratamientos oncológicos

Teresa López-Fernández et al.

REVISTA ESPANOLA DE CARDIOLOGIA (2017)

Article Hematology

Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study

Luis Jara-Palomares et al.

THROMBOSIS RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility

Ciro Santoro et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)

Review Cardiac & Cardiovascular Systems

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

Andreu Porta-Sanchez et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)

Article Medical Laboratory Technology

High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury

Melissa Jones et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2017)

Article Oncology

Temporal trends and outcomes of acute myocardial infarction in patients with cancer

Naga Venkata Pothineni et al.

ANNALS OF TRANSLATIONAL MEDICINE (2017)

Article Education, Scientific Disciplines

Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy

Mary C. Barber et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)

Article Oncology

Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Todd M. Gibson et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Article Cardiac & Cardiovascular Systems

Cancer Treatment-Induced Arrhythmias Focus on Chemotherapy and Targeted Therapies

Vitaly Buza et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

Mathew S. Maurer et al.

CIRCULATION (2017)

Review Cardiac & Cardiovascular Systems

Radiation-induced valvular heart disease

Dorothy M. Gujral et al.

HEART (2016)

Article Cardiac & Cardiovascular Systems

Cause and Long-Term Outcome of Cardiac Tamponade

Cristina Sanchez-Enrique et al.

AMERICAN JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer

Yusuke Watanabe et al.

AMERICAN JOURNAL OF CARDIOLOGY (2016)

Article Pharmacology & Pharmacy

Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma

Mary E. Roth et al.

AMERICAN JOURNAL OF THERAPEUTICS (2016)

Review Cardiac & Cardiovascular Systems

Vascular Toxicities of Cancer Therapies The Old and the New - An Evolving Avenue

Joerg Herrmann et al.

CIRCULATION (2016)

Review Cardiac & Cardiovascular Systems

Shared Risk Factors in Cardiovascular Disease and Cancer

Ryan J. Koene et al.

CIRCULATION (2016)

Review Cardiac & Cardiovascular Systems

Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment

Carrie G. Lenneman et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction

Lynn A. Beer et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention

Grant W. Reed et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)

Review Medicine, General & Internal

Radiation-induced heart disease: A practical guide to diagnosis and management

Eoin Donnellan et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy

Yong-Joon Lee et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study

Daniel J. Lenihan et al.

JOURNAL OF CARDIAC FAILURE (2016)

Article Cardiac & Cardiovascular Systems

Incidence rate of primary cardiac tumors: a 14-year population study

Alberto Cresti et al.

JOURNAL OF CARDIOVASCULAR MEDICINE (2016)

Article Oncology

Statins Are Associated With Reduced Mortality in Multiple Myeloma

Kristen Marie Sanfilippo et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Oncology

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Pooja P. Advani et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Oncology

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

Frederika A. van Nimwegen et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Neurosciences

Predicting drug-induced QT prolongation and torsades de pointes

Dan M. Roden

JOURNAL OF PHYSIOLOGY-LONDON (2016)

Review Oncology

The Utility of Exercise Testing in Patients with Lung Cancer

Duc Ha et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Review Oncology

The 2015 WHO Classification of Tumors of the Heart and Pericardium

Allen Burke et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Article Medicine, General & Internal

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. dbj Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Medicine, General & Internal

Cardiovascular Toxic Effects of Targeted Cancer Therapies

Javid J. Moslehi

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

G. N. Hortobagyi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Pharmacology & Pharmacy

Influence of steroid hormones on ventricular repolarization

Joe-Elie Salem et al.

PHARMACOLOGY & THERAPEUTICS (2016)

Article Hematology

Predictors of recurrent venous thromboembolism and bleeding on anticoagulation

Laurel A. Menapace et al.

THROMBOSIS RESEARCH (2016)

Article Hematology

Epidemiology of venous thromboembolism in the Framingham Heart Study

Marja K. Puurunen et al.

THROMBOSIS RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis

Oluseye Ogunmoroti et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Article Cardiac & Cardiovascular Systems

Which QT Correction Formulae to Use for QT Monitoring?

Bert Vandenberk et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Review Cardiac & Cardiovascular Systems

Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation

Federico Viganego et al.

CURRENT CARDIOLOGY REPORTS (2016)

Review Cardiac & Cardiovascular Systems

Echocardiography in Pregnancy: Part 2

Meena Narayanan et al.

CURRENT CARDIOLOGY REPORTS (2016)

Article Cardiac & Cardiovascular Systems

Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy

Lin Wang et al.

AMERICAN JOURNAL OF CARDIOLOGY (2015)

Article Pathology

Chemotherapy-Induced Pulmonary Hypertension Role of Alkylating Agents

Benoit Ranchoux et al.

AMERICAN JOURNAL OF PATHOLOGY (2015)

Article Cardiac & Cardiovascular Systems

ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity

Frances Belmonte et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)

Article Biophysics

Arrhythmias in the setting of hematopoietic cell transplants

E. S. Tonorezos et al.

BONE MARROW TRANSPLANTATION (2015)

Article Cardiac & Cardiovascular Systems

Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function

Runyawan Chotenimitkhun et al.

CANADIAN JOURNAL OF CARDIOLOGY (2015)

Review Oncology

Lifestyle and Cancer Risk

Verena A. Katzke et al.

CANCER JOURNAL (2015)

Article Cardiac & Cardiovascular Systems

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

Daniela Cardinale et al.

CIRCULATION (2015)

Review Oncology

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Pooja Ghatalia et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)

Review Public, Environmental & Occupational Health

Cancer Chemotherapy and Cardiac Arrhythmias: A Review

Juan Tamargo et al.

DRUG SAFETY (2015)

Review Cardiac & Cardiovascular Systems

State of the Art: Newer biomarkers in heart failure

Rudolf A. de Boer et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

Article Medicine, General & Internal

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial

Agnes Y. Y. Lee et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Cardiac & Cardiovascular Systems

Pulmonary Vein Isolation for Atrial Fibrillation in the Postpneumonectomy Population: A Feasibility, Safety, and Outcomes Study

Arun Kanmanthareddy et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)

Review Oncology

Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

Javid J. Moslehi et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Cardiac & Cardiovascular Systems

Vascular and Metabolic Implications of Novel Targeted Cancer Therapies Focus on Kinase Inhibitors

Weijuan Li et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Early and Late Outcomes of Surgical Treatment in Carcinoid Heart Disease

Heidi M. Connolly et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Cardiovascular Health of Patients With Cancer and Cancer Survivors A Roadmap to the Next Level

Ana Barac et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors The EACVI/ASE Inter-Vendor Comparison Study

Konstantinos E. Farsalinos et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)

Article Oncology

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

David J. Cutter et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Hematology

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study

C. W. Francis et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Article Medicine, General & Internal

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma

John Radford et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

Risk of Device Malfunction in Cancer Patients with Implantable Cardiac Device Undergoing Radiotherapy: A Population-Based Cohort Study

Tomas Zaremba et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2015)

Editorial Material Geriatrics & Gerontology

A framework for prescription in exercise-oncology research

John P. Sasso et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)

Article Medicine, General & Internal

Cardiovascular Disease After Hodgkin Lymphoma Treatment 40-Year Disease Risk

Frederika A. van Nimwegen et al.

JAMA INTERNAL MEDICINE (2015)

Article Oncology

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

David J. Cutter et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Cardiac & Cardiovascular Systems

Protective effects of spironolactone against anthracycline-induced cardiomyopathy

Mahmut Akpek et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

Article Health Care Sciences & Services

Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway

Jozette J. C. Stienen et al.

JMIR RESEARCH PROTOCOLS (2015)

Article Cardiac & Cardiovascular Systems

Prediction of 30-Year Risk for Cardiovascular Mortality by Fitness and Risk Factor Levels The Cooper Center Longitudinal Study

Chanaka D. Wickramasinghe et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)

Review Cardiac & Cardiovascular Systems

The clinical presentation and management of carcinoid heart disease

R. Dobson et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Outcomes After Percutaneous Coronary Intervention With Stents in Patients Treated With Thoracic External Beam Radiation for Cancer

Jackson J. Liang et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2014)

Article Pharmacology & Pharmacy

Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma

S. Limat et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)

Review Cardiac & Cardiovascular Systems

Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy

Paaladinesh Thavendiranathan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Insights Into Onco-Cardiology Atrial Fibrillation in Cancer

Dimitrios Farmakis et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Prevention of Anthracycline-Induced Cardiotoxicity

Pimprapa Vejpongsa et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Article Medicine, General & Internal

Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology

Joerg Herrmann et al.

MAYO CLINIC PROCEEDINGS (2014)

Article Cardiac & Cardiovascular Systems

Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection

Kazuaki Negishi et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)

Article Cardiac & Cardiovascular Systems

Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Ghideon Ezaz et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Review Pharmacology & Pharmacy

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

Anne Polk et al.

BMC PHARMACOLOGY & TOXICOLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Cardiac Masses on Cardiac CT: A Review

David Kassop et al.

CURRENT CARDIOVASCULAR IMAGING REPORTS (2014)

Article Cardiac & Cardiovascular Systems

Cardiovascular magnetic resonance in pregnancy: Insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study

Robin A. Ducas et al.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2014)

Article Cardiac & Cardiovascular Systems

Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention

Matthijs A. Velders et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Hematology

Incidence of Supraventricular Arrhythmias during Autologous Peripheral Blood Stem Cell Transplantation

Abhishek Singla et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)

Article Hematology

Systemic light chain amyloidosis: an update for treating physicians

Giampaolo Merlini et al.

BLOOD (2013)

Review Public, Environmental & Occupational Health

Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)

Rashmi R. Shah et al.

DRUG SAFETY (2013)

Article Cardiac & Cardiovascular Systems

2013 ESC guidelines on the management of stable coronary artery disease

Gilles Montalescot et al.

EUROPEAN HEART JOURNAL (2013)

Letter Cardiac & Cardiovascular Systems

Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients

Yu-feng Hu et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)

Article Oncology

Malfunctions of Implantable Cardiac Devices in Patients Receiving Proton Beam Therapy: Incidence and Predictors

Daniel R. Gomez et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer

Gregory T. Armstrong et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies

Xavier Bosch et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity

Kazuaki Negishi et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)

Article Medicine, General & Internal

Statin Use and Reduced Cancer-Related Mortality

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Medicine, General & Internal

Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?

Monte S. Willis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

Sarah C. Darby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Cardiac & Cardiovascular Systems

Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives

Steven M. Bair et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2013)

Article Medicine, General & Internal

Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England

Alyshah Abdul Sultan et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Cardiac & Cardiovascular Systems

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

Richard M. Steingart et al.

AMERICAN HEART JOURNAL (2012)

Article Cardiac & Cardiovascular Systems

Capecitabine-Induced Chest Pain Relieved by Diltiazem

Andrew P. Ambrosy et al.

AMERICAN JOURNAL OF CARDIOLOGY (2012)

Article Hematology

Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure

Giovanni Palladini et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)

Article Hematology

Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study

Alyshah Abdul Sultan et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Article Oncology

Nutrition and Physical Activity Guidelines for Cancer Survivors

Cheryl L. Rock et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Article Cardiac & Cardiovascular Systems

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

David Montani et al.

CIRCULATION (2012)

Article Cardiac & Cardiovascular Systems

Morphological and Functional Adaptation of the Maternal Heart During Pregnancy

Oana Savu et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2012)

Letter Cardiac & Cardiovascular Systems

Response to Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population

S. W. Yusuf et al.

CLINICAL CARDIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population

Syed Wamique Yusuf et al.

CLINICAL CARDIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Real Time Three-Dimensional Echocardiography Evaluation of Intracardiac Masses

Elisa Zaragosa-Macias et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT

Kambiz Rahbar et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Jersey Chen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction

Jennifer L. Dorosz et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Oncology

Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors

Darren R. Feldman et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)

Article Medicine, General & Internal

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

Melanie Demers et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cardiac & Cardiovascular Systems

In patients with carcinoid syndrome undergoing valve replacement, will a biological valve have acceptable durability?

Nigel Mabvuure et al.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2012)

Article Hematology

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML

Karl J. Aichberger et al.

AMERICAN JOURNAL OF HEMATOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System

Babak Nazer et al.

CIRCULATION (2011)

Article Cardiac & Cardiovascular Systems

Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality

Sachin Gupta et al.

CIRCULATION (2011)

Article Cardiac & Cardiovascular Systems

Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology

Thomas Eschenhagen et al.

EUROPEAN JOURNAL OF HEART FAILURE (2011)

Letter Cardiac & Cardiovascular Systems

Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy

Zeydin Acar et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Characterization of Cardiac Tumors in Children by Cardiovascular Magnetic Resonance Imaging A Multicenter Experience

Rebecca S. Beroukhim et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Diseased Skeletal Muscle A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T

Allan S. Jaffe et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Letter Medicine, General & Internal

Reversible Cardiomyopathy Associated with Sunitinib and Sorafenib

Imran Uraizee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Cardiac & Cardiovascular Systems

Carcinoid heart disease: Case and literature review

Michiel Dumoulein et al.

ACTA CARDIOLOGICA (2010)

Review Oncology

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

Melinda Protani et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Cardiac & Cardiovascular Systems

Features of Carcinoid Heart Disease Identified by 2-and 3-Dimensional Echocardiography and Cardiac MRI

Sanjeev Bhattacharyya et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2010)

Article Oncology

RADIATION DOSE-VOLUME EFFECTS IN THE HEART

Giovanna Gagliardi et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)

Review Oncology

Energetics in Colorectal and Prostate Cancer

Jeffrey A. Meyerhardt et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Oncology

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

Daniela Cardinale et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Cardiac & Cardiovascular Systems

B-Type Natriuretic Peptide in Pregnant Women With Heart Disease

David Tanous et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Anthracycline-Induced Cardiomyopathy Clinical Relevance and Response to Pharmacologic Therapy

Daniela Cardinale et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Medicine, General & Internal

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Cardiac & Cardiovascular Systems

Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis

DaLi Feng et al.

CIRCULATION (2009)

Article Cardiac & Cardiovascular Systems

SYSTEMIC DISORDERS IN HEART DISEASE Radiation induced heart disease

Paul A. Heidenreich et al.

HEART (2009)

Review Oncology

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

Alok A. Khorana et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Predictors of Coronary Stent Thrombosis The Dutch Stent Thrombosis Registry

Jochem W. van Werkum et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Review Cardiac & Cardiovascular Systems

Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management

Edward T. H. Yeh et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease

Sanjeev Bhattacharyya et al.

AMERICAN JOURNAL OF CARDIOLOGY (2008)

Article Oncology

Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy

Xiong Wei et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Letter Medicine, General & Internal

Home blood-pressure monitoring in patients receiving sunitinib

Michel Azizi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Tammy F. Chu et al.

LANCET (2007)

Article Cardiac & Cardiovascular Systems

Carcinoid heart disease

Sanjeev Bhattacharyya et al.

CIRCULATION (2007)

Review Oncology

Innovations in image-guided radiotherapy

Dirk Verellen et al.

NATURE REVIEWS CANCER (2007)

Article Cardiac & Cardiovascular Systems

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

DaLi Feng et al.

CIRCULATION (2007)

Article Medicine, General & Internal

Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer

Jeffrey A. Meyerhardt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Medicine, General & Internal

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

Maud M. Geenen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Meeting Abstract Oncology

Trastuzumab treatment and the risk of central nervous system (CNS) metastases

M. C. Pinder et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Letter Hematology

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Review Oncology

Radiation-induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiologic data?

Susanne Schultz-Hector et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Medicine, General & Internal

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer

Russell D. Hull et al.

AMERICAN JOURNAL OF MEDICINE (2006)

Article Oncology

Dietary patterns and survival after breast cancer diagnosis

CH Kroenke et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Medicine, General & Internal

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

MJ Piccart-Gebhart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

EH Romond et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Oncology

Cardiac tumours: diagnosis and management

J Butany et al.

LANCET ONCOLOGY (2005)

Article Oncology

Weight, weight gain, and survival after breast cancer diagnosis

CH Kroenke et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging

JN Kirkpatrick et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Carcinoid heart disease: Presentation, diagnosis, and management

DJ Fox et al.

HEART (2004)

Article Cardiac & Cardiovascular Systems

Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy

JA Crestanello et al.

ANNALS OF THORACIC SURGERY (2004)

Article Medicine, General & Internal

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

SE Lipshultz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy

MC Hull et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Oncology

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

G Cianci et al.

BRITISH JOURNAL OF CANCER (2003)

Review Oncology

Radiation-associated cardiovascular disease

MJ Adams et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)

Article Oncology

Autonomic nervous system dysfunction in advanced cancer

D Walsh et al.

SUPPORTIVE CARE IN CANCER (2002)

Article Oncology

Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil

N Frickhofen et al.

ANNALS OF ONCOLOGY (2002)

Article Medicine, General & Internal

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

D Bergqvist et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Review Cell Biology

Untangling the ErbB signalling network

Y Yarden et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)